Detalhe da pesquisa
1.
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
N Engl J Med
; 386(13): 1207-1220, 2022 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35172051
2.
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.
Immunology
; 166(1): 68-77, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35156709
3.
Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers.
Clin Exp Immunol
; 209(1): 90-98, 2022 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35522978
4.
Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.
Transfusion
; 62(7): 1347-1354, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35588314
5.
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.
Transfusion
; 61(10): 2837-2843, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34342366
6.
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people.
Immun Ageing
; 18(1): 34, 2021 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34416887
7.
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Lancet
; 397(10279): 1057-1058, 2021 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33640038
8.
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort.
Lancet Reg Health Eur
; 36: 100809, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38111727
9.
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Lancet Rheumatol
; 6(2): e92-e104, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38267107
10.
Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.
J Infect
; 87(5): 420-427, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37689394
11.
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.
Nat Commun
; 14(1): 5139, 2023 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37612310
12.
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.
Lancet Infect Dis
; 23(9): 1042-1050, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37336224
13.
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments.
Sci Rep
; 13(1): 13912, 2023 08 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37626085
14.
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
Nat Commun
; 14(1): 5948, 2023 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37741831
15.
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis.
EClinicalMedicine
; 58: 101926, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37034357
16.
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
iScience
; 26(6): 106937, 2023 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37275518
17.
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
J Infect
; 87(3): 230-241, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37331429
18.
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
J Infect
; 87(4): 315-327, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37579793
19.
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.
mBio
; 14(5): e0121223, 2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37655880
20.
Extended interval BNT162b2 vaccination enhances peak antibody generation.
NPJ Vaccines
; 7(1): 14, 2022 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35087066